<h4>Background</h4>Immune-mediated necrotizing myopathy (IMNM) is a rare autoimmune disease characterized by prominent muscle involvement and usually associated with serum autoantibodies targeting signal recognition particle (SRP) or 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR). Here, HMGCR is linked to autoimmune disease.